Opsens Inc (OPSSF) 0.6879 $OPSSF
United States Biomedical Sensors Market 2015 - Growth, Trends & Forecasts 2014-2020 for the $4.5 Billion Industry
M2 - Thu Jul 02, 10:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxv696/us_biomedical) has announced the addition of the "US Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The US Biomedical Sensors market is estimated at $4.50 billion by 2018 at a CAGR of 7.43% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/bx...biomedical
HNSN: 0.90 (+0.02)
Russia Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vm5z2t/russia_biomedical) has announced the addition of the "Russia Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Russia Biomedical Sensors market is estimated at $0.25 billion by 2018 at a CAGR of 2.94% over the period 2014-2020. The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/vm...biomedical
HNSN: 0.90 (+0.02)
Italy Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hktjw9/italy_biomedical) has announced the addition of the "Italy Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Italy Biomedical Sensors market is estimated at $0.17 billion by 2018 at a CAGR of 0.54% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/hk...biomedical
HNSN: 0.90 (+0.02)
Opsens - Results for third quarter 2015
CNW Group - Thu Jul 02, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) today released results for its third quarter ended May 31, 2015.
OPS.VN: 0.870 (+0.030)
OPSENS Moves FFR Activities to Increase Manufacturing Capacity
CNW Group - Thu Jun 25, 9:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) announces that in light of the positive feedback on the performance of its products developed to measure Fractional Flow Reserve ("FFR" , the OptoWire and OptoMonitor ("Opsens' FFR products" , and the recent FDA approval for the commercialization of these products in the U.S., the Company is going forward with a massive expansion to increase the manufacturing capacity and accommodate its growing number of employees.
OPS.VN: 0.870 (+0.030)
Latin America Biomedical Sensors Market 2015-2020: Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) & Applications (Pharmaceutical, Healthcare)
M2 - Wed Jun 24, 3:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4x8wr/latin_america) has announced the addition of the "Latin America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Latin America Biomedical Sensors market is estimated at $0.65 billion by 2018 at a CAGR of 2.04% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Mexico closely followed by Brazil account for highest market share with Brazil projecting a higher growth rate over the forecasted period. The Latin America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical), Application (Pharmaceutical, Healthcare). Company Profiles - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/w4...in_america
HNSN: 0.90 (+0.02)
IIROC Trade Resumption - Opsens Inc.
Newsfile Corp - Mon Jun 15, 10:47AM CDT
Trading resumes in:
OPSENS gets clearance to sell FFR products in the United States
CNW Group - Mon Jun 15, 10:26AM CDT
Opsens Inc. (TSXV:OPS) (OTCQX:OPSSF) ("Opsens" or the "Company" today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . This measure is used to optimize the diagnostic and guide the treatment of patients with coronary heart disease. This clearance gives Opsens permission to sell its FFR products in the United States, the world's largest FFR market.
OPS.VN: 0.870 (+0.030)
IIROC Trade Halt - Opsens Inc.
Newsfile Corp - Mon Jun 15, 7:02AM CDT
The following issues have been halted by IIROC:
North America Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020
M2 - Fri Jun 12, 7:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8zljc6/north_america) has announced the addition of the "North America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The North America Biomedical Sensors market is estimated at $5.31 billion by 2018 at a CAGR of 6.97% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. The North America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, Biochemical), and Application (Pharmaceutical, Healthcare). This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. The report also considers key trends that will impact the industry and profiles over 10 leading suppliers of North American Biomedical Sensors Market. Some of the top companies mentioned in the report are Zephyr Technology Corp, Entra Health Systems, FISO Technologies Inc, Lumasense Technologies, Neoptix and Others. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Featured: - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/8z...th_america About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HNSN: 0.90 (+0.02)
Opsens announces first use of its FFR products by Dr. Nico Pijls
CNW Group - Wed May 20, 1:00AM CDT
Opsens inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the first use of the OptoWire and OptoMonitor, its products to measure Fractional Flow Reserve ("FFR" , by Dr. Nico Pijls in Eindhoven, the Netherlands. Opsens' FFR products are designed to optimize the diagnosis and guide the treatment of patients with coronary heart disease.
OPS.VN: 0.870 (+0.030)
Opsens - Second quarter 2015 results
CNW Group - Tue Apr 21, 10:58AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX:OPSSF) today released results for its second quarter ended February 28, 2015.
OPS.VN: 0.870 (+0.030)
Opsens' shares now traded on the OTCQX marketplace in U.S.
CNW Group - Tue Mar 31, 6:00AM CDT
Opsens Inc. ("Opsens" or the "Company" (TSXV: OPS) (OTCQX: OPSSF) announces that its common shares began trading under the ticker symbol "OPSSF" on the OTCQX marketplace in the United States, effective today. OTCQX, operated by OTC Markets Group Inc., offers the best informed and most efficient trading for established, global and growth companies. Opsens' shares will continue trading on the TSX Venture Exchange under the ticker symbol "OPS."
OPS.VN: 0.870 (+0.030)
United States Biomedical Sensors Market 2015 - Growth, Trends & Forecasts 2014-2020 for the $4.5 Billion Industry
M2 - Thu Jul 02, 10:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxv696/us_biomedical) has announced the addition of the "US Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The US Biomedical Sensors market is estimated at $4.50 billion by 2018 at a CAGR of 7.43% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/bx...biomedical
HNSN: 0.90 (+0.02)
Russia Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vm5z2t/russia_biomedical) has announced the addition of the "Russia Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Russia Biomedical Sensors market is estimated at $0.25 billion by 2018 at a CAGR of 2.94% over the period 2014-2020. The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/vm...biomedical
HNSN: 0.90 (+0.02)
Italy Biomedical Sensors (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) Market - Growth, Trends & Forecasts (2014-2020)
M2 - Thu Jul 02, 9:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hktjw9/italy_biomedical) has announced the addition of the "Italy Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Italy Biomedical Sensors market is estimated at $0.17 billion by 2018 at a CAGR of 0.54% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Mentioned - Zephyr Technology Corp. - Entra Health Systems - Fiso Technologies Inc. - Lumasense Technologies - Neoptix - Opsens,Inc. - Rjc Enterprises Llc - Infraredx, Inc. - Iss, Inc. - Srico - Adinstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/hk...biomedical
HNSN: 0.90 (+0.02)
Opsens - Results for third quarter 2015
CNW Group - Thu Jul 02, 7:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) today released results for its third quarter ended May 31, 2015. OPS.VN: 0.870 (+0.030)
OPSENS Moves FFR Activities to Increase Manufacturing Capacity
CNW Group - Thu Jun 25, 9:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) announces that in light of the positive feedback on the performance of its products developed to measure Fractional Flow Reserve ("FFR" , the OptoWire and OptoMonitor ("Opsens' FFR products" , and the recent FDA approval for the commercialization of these products in the U.S., the Company is going forward with a massive expansion to increase the manufacturing capacity and accommodate its growing number of employees. OPS.VN: 0.870 (+0.030)
Latin America Biomedical Sensors Market 2015-2020: Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical) & Applications (Pharmaceutical, Healthcare)
M2 - Wed Jun 24, 3:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w4x8wr/latin_america) has announced the addition of the "Latin America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The Latin America Biomedical Sensors market is estimated at $0.65 billion by 2018 at a CAGR of 2.04% over the period 2014-2020 The near future will bring Biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. Mexico closely followed by Brazil account for highest market share with Brazil projecting a higher growth rate over the forecasted period. The Latin America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, and Biochemical), Application (Pharmaceutical, Healthcare). Company Profiles - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/w4...in_america
HNSN: 0.90 (+0.02)
IIROC Trade Resumption - Opsens Inc.
Newsfile Corp - Mon Jun 15, 10:47AM CDT
Trading resumes in:
OPSENS gets clearance to sell FFR products in the United States
CNW Group - Mon Jun 15, 10:26AM CDT
Opsens Inc. (TSXV:OPS) (OTCQX:OPSSF) ("Opsens" or the "Company"
today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR" . This measure is used to optimize the diagnostic and guide the treatment of patients with coronary heart disease. This clearance gives Opsens permission to sell its FFR products in the United States, the world's largest FFR market. OPS.VN: 0.870 (+0.030)
IIROC Trade Halt - Opsens Inc.
Newsfile Corp - Mon Jun 15, 7:02AM CDT
The following issues have been halted by IIROC:
North America Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020
M2 - Fri Jun 12, 7:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8zljc6/north_america) has announced the addition of the "North America Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" report to their offering. The North America Biomedical Sensors market is estimated at $5.31 billion by 2018 at a CAGR of 6.97% over the period 2014-2020 The near future will bring biomedical sensors that are adaptable to the genetic formulation of each individual. These sensors can be set to trigger alerts when unpredictable readings are enlisted, screen the existence of toxic agents in the blood, or empower drug directly into the circulatory system. These Sensors are set to find its demand in the healthcare industry. The Biomedical Sensors are driven by the increased demand in the hazardous environments, utilization in situations resulting natural disasters, increased demand in healthcare sector for diabetic and heart patients, and embedded monitoring of the patients. The advancement in technology has made possible to build a Biomedical Sensor using Nano and Micro technology making it tiny, robust, smart and cost-effective. The early detection of irregularities in the health status of the patients will contribute to the better quality of life. Even though Biomedical Sensors are playing a major role in life saving situation, it is facing certain challenges such as patient's safety and comfort due to strong electromagnetic fields, transferring energy from external to internal parts with high efficiency and high data rates, limited computation and data storage, and ultra-low power consumption. The North America Biomedical Sensors Market is segmented on the basis of Type (Temperature, Accelerometer, Pressure, Chemical, Biochemical), and Application (Pharmaceutical, Healthcare). This report describes a detailed study of the Porter's five forces analysis of the market. All the five major factors in these markets have been quantified using the internal key parameters governing each of them. It also covers the market landscape of these players which includes the key growth strategies and competition analysis. The report also considers key trends that will impact the industry and profiles over 10 leading suppliers of North American Biomedical Sensors Market. Some of the top companies mentioned in the report are Zephyr Technology Corp, Entra Health Systems, FISO Technologies Inc, Lumasense Technologies, Neoptix and Others. Key Topics Covered: 1. Introduction 2. Key Findings 3. Market Overview & Dynamics 4. Introduction 5. Porter's Five Forces Analysis 6. Market Segmentation 7. Company Profiles 8. Investment Analysis 9. Future of Biomedical Sensors Market Companies Featured: - Zephyr Technology Corp. - Entra Health Systems - FISO Technologies Inc. - LumaSense Technologies - Neoptix - Opsens,Inc. - RJC Enterprises LLC - Infraredx, Inc. - ISS, Inc. - SRICO - ADInstruments - Maquet - Nonin Medical Inc. - Hansen Medical - Measurand Inc. For more information visit http://www.researchandmarkets.com/research/8z...th_america About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
HNSN: 0.90 (+0.02)
Opsens announces first use of its FFR products by Dr. Nico Pijls
CNW Group - Wed May 20, 1:00AM CDT
Opsens inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) is pleased to announce the first use of the OptoWire and OptoMonitor, its products to measure Fractional Flow Reserve ("FFR" , by Dr. Nico Pijls in Eindhoven, the Netherlands. Opsens' FFR products are designed to optimize the diagnosis and guide the treatment of patients with coronary heart disease. OPS.VN: 0.870 (+0.030)
Opsens - Second quarter 2015 results
CNW Group - Tue Apr 21, 10:58AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX:OPSSF) today released results for its second quarter ended February 28, 2015. OPS.VN: 0.870 (+0.030)
Opsens' shares now traded on the OTCQX marketplace in U.S.
CNW Group - Tue Mar 31, 6:00AM CDT
Opsens Inc. ("Opsens" or the "Company"
(TSXV: OPS) (OTCQX: OPSSF) announces that its common shares began trading under the ticker symbol "OPSSF" on the OTCQX marketplace in the United States, effective today. OTCQX, operated by OTC Markets Group Inc., offers the best informed and most efficient trading for established, global and growth companies. Opsens' shares will continue trading on the TSX Venture Exchange under the ticker symbol "OPS." OPS.VN: 0.870 (+0.030)
